New York State Teachers Retirement System Sells 200 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

New York State Teachers Retirement System lowered its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 0.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 75,854 shares of the company’s stock after selling 200 shares during the quarter. New York State Teachers Retirement System owned 0.08% of Acadia Healthcare worth $5,898,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Headlands Technologies LLC acquired a new position in Acadia Healthcare during the third quarter valued at approximately $25,000. Point72 Hong Kong Ltd acquired a new position in Acadia Healthcare during the first quarter valued at approximately $38,000. Fifth Third Bancorp grew its holdings in Acadia Healthcare by 25.5% during the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after purchasing an additional 136 shares during the period. Belpointe Asset Management LLC grew its holdings in Acadia Healthcare by 75.7% during the first quarter. Belpointe Asset Management LLC now owns 982 shares of the company’s stock valued at $71,000 after purchasing an additional 423 shares during the period. Finally, DekaBank Deutsche Girozentrale acquired a new position in shares of Acadia Healthcare in the third quarter valued at approximately $96,000.

Analyst Ratings Changes

Several research analysts have recently weighed in on ACHC shares. Barclays started coverage on shares of Acadia Healthcare in a report on Wednesday, March 6th. They issued an “overweight” rating and a $100.00 price target for the company. TheStreet upgraded shares of Acadia Healthcare from a “c” rating to a “b-” rating in a report on Monday, March 4th. UBS Group upped their price target on shares of Acadia Healthcare from $88.00 to $102.00 and gave the company a “buy” rating in a report on Wednesday, February 28th. TD Cowen boosted their price objective on shares of Acadia Healthcare from $86.00 to $101.00 and gave the stock an “outperform” rating in a research report on Friday, March 1st. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $94.00 price objective on shares of Acadia Healthcare in a research report on Monday, March 4th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, Acadia Healthcare has an average rating of “Hold” and a consensus target price of $91.22.

Insider Activity

In other news, Director Wade D. Miquelon sold 2,203 shares of the stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the transaction, the director now directly owns 46,074 shares of the company’s stock, valued at $3,934,258.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 2.80% of the company’s stock.

Acadia Healthcare Stock Performance

NASDAQ ACHC opened at $73.18 on Friday. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48. The firm’s fifty day moving average price is $80.10 and its two-hundred day moving average price is $77.50. Acadia Healthcare Company, Inc. has a 1 year low of $66.49 and a 1 year high of $87.77. The firm has a market capitalization of $6.76 billion, a P/E ratio of -292.71, a price-to-earnings-growth ratio of 2.24 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, February 28th. The company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.80 by $0.05. The firm had revenue of $742.80 million for the quarter, compared to analyst estimates of $727.60 million. Acadia Healthcare had a negative net margin of 0.74% and a positive return on equity of 11.21%. The company’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.70 earnings per share. As a group, research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.57 EPS for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.